Nektar Therapeutics
NKTR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $41,032 | $42,988 | $38,894 | $44,252 |
| Short-Term Investments | $229,176 | $132,915 | $179,738 | $210,974 |
| Receivables | $1,289 | $1,351 | $1,714 | $1,609 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $281,357 | $186,566 | $229,913 | $261,292 |
| Property Plant & Equip (Net) | $9,997 | $10,573 | $11,161 | $11,824 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $4,837 | $5,371 | $9,776 | $26,087 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5,156 | $5,024 | $5,391 | $4,647 |
| Total NC Assets | $19,990 | $20,968 | $26,328 | $42,558 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $301,347 | $207,534 | $256,241 | $303,850 |
| Liabilities | – | – | – | – |
| Payables | $15,563 | $14,281 | $17,834 | $11,560 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8,606 | $6,549 | $5,026 | $5,553 |
| Total Curr. Liab. | $66,340 | $71,391 | $70,930 | $61,400 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $80,189 | $86,209 | $93,078 | $99,017 |
| Total NC Liab. | $149,921 | $160,354 | $171,573 | $181,713 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $91,915 | $96,156 | $100,337 | $102,564 |
| Total Liabilities | $216,261 | $231,745 | $242,503 | $243,113 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $2 | $1 | $19 | $19 |
| Retained Earnings | -$3,724,207 | -$3,688,685 | -$3,647,092 | -$3,596,210 |
| AOCI | $56 | -$14 | $39 | $61 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $85,086 | -$24,211 | $13,738 | $60,737 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $301,347 | $207,534 | $256,241 | $303,850 |
| Net Debt | -$41,032 | -$42,988 | -$38,894 | -$44,252 |